Synonyms: compound 18a5 [PMID: 40013713]
Compound class:
Synthetic organic
Comment: Expression of annexin A3 (ANXA3) protein is elevated in a significant proportion of triple-negative breast cancer (TNBC) clinical samples, and this is associated with poor prognosis. This molecule behaves as a degrader of the ANXA3 protein, thus offering a novel mechanistic approach with therapeutic potential in TNBC [1].
|
|
Bioactivity Comments |
Degrader 18a5 has a DC50 of ~6μM vs. ANXA3 protein. It has anti-tumour activity in a TNBC tumour xenograft model. |
Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|